绿达生品牌怎么样 申请店铺

我要投票 绿达生在兽药行业中的票数:565 更新时间:2026-01-19
绿达生是哪个国家的品牌?「绿达生」是 哈尔滨绿达生动物药业有限公司 旗下著名品牌。该品牌发源于黑龙江哈尔滨市,由创始人郝敬友在2004-06-22期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力绿达生品牌出海!将品牌入驻外推网,定制绿达生品牌推广信息,可以显著提高绿达生产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

绿达生怎么样

哈尔滨绿达生动物药业有限公司,始建于1997年,公司前身为东北农业大学科发兽药厂,有多年的兽药研制和生产历史,2004年6月企业移地新建厂,为有限公司,厂区占地面积17000平方米,建筑面积8000平方米,注册资金2000万元。公司生产及销售猪、马、牛、羊、禽、狐、貂、兔、鹿、宠物及鱼药和饲料添加剂。公司现有职工人数210人,大专以上学历79人,占员工总数38%;科技人员32人,占职工总数15%;平均年龄35岁;其中博士10人,硕士4人;高级职称10人,中级职称4人。

绿达生动物药业深知国内外兽药市场的发展趋势,牢牢把握 用科技打造高效药,用良心打造合格药 的理念。公司引进制药设备,从药用植物中提取有效成分应用于兽药中,坚决杜绝动物食品中的药物残留。公司2005年8月通过农业部GMP认证,一次性通过最终可灭菌小容量注射剂、非最终灭菌无菌粉末注射剂、西药粉剂、中药散剂、预混剂五种剂型。

2008年公司又通过了饲料添加剂和添加剂预混合饲料两种剂型的验收。2010年9月高分通过GMP复验。2011年再次高分通过颗粒剂、片剂、口服液、外用固体杀虫剂、可灭菌非静脉大容量注射剂与中药提取六个GMP剂型。公司目前为东北三省剂型最全的兽药生产企业,拥有注射剂、粉剂等产品300余种销往全国各地,深受广大用户好评,近十年来,公司已服务全国近3000家养殖场。

公司以地理位置为依托,与东北农业大学、黑龙江八一农垦大学、黑龙江生物工程技术学院展开校企合作,实现研、产、销一条龙。公司严把质量关,加强新产品的研发力度,与哈尔滨兽医研究所合作进行疾病诊断鉴定,与东北农业大学动物药学院、佳木斯大学药学院、黑龙江省兽医研究所合作进行产品研发及剂型研究。


Harbin lvdasheng Animal Pharmaceutical Co., Ltd., founded in 1997, formerly known as Kefa animal pharmaceutical factory of Northeast Agricultural University, has many years of animal pharmaceutical research and production history. In June 2004, the enterprise moved to a new factory, which is a limited company. The factory covers an area of 17000 square meters, with a building area of 8000 square meters and a registered capital of 20 million yuan. The company produces and sells medicines and feed additives for pigs, horses, cattle, sheep, birds, foxes, minks, rabbits, deer, pets and fish. The company has 210 employees, 79 with college degree or above, accounting for 38% of the total number of employees; 32 scientific and technological personnel, accounting for 15% of the total number of employees; the average age is 35 years old, including 10 doctors, 4 masters; 10 senior titles, 4 intermediate titles. Lvdasheng animal medicine industry is well aware of the development trend of domestic and foreign animal medicine market, firmly grasp the concept of building high-efficiency drugs with science and technology, and building qualified drugs with conscience. The company introduces pharmaceutical equipment, extracts effective ingredients from medicinal plants and applies them to veterinary medicine, and resolutely puts an end to drug residues in animal food. In August 2005, the company passed the GMP certification of the Ministry of agriculture, and passed the final sterilized small volume injection, non final sterilized sterile powder injection, western medicine powder, traditional Chinese medicine powder and premix five dosage forms. In 2008, the company passed the acceptance of two dosage forms of feed additive and additive premixed feed. In September 2010, GMP retest was passed with high score. In 2011, six GMP dosage forms were extracted by granule, tablet, oral liquid, external solid insecticide, sterile non intravenous large volume injection and traditional Chinese medicine. At present, the company is the most complete veterinary drug production enterprise in the three northeastern provinces, with more than 300 kinds of injection, powder and other products sold to all parts of the country, well received by the majority of users. In the past decade, the company has served nearly 3000 farms in the country. Relying on its geographical location, the company has launched school enterprise cooperation with Northeast Agricultural University, Heilongjiang Bayi Agricultural University and Heilongjiang College of biological engineering technology to realize the integration of research, production and marketing. The company strictly controls the quality, strengthens the research and development of new products, cooperates with Harbin Veterinary Research Institute for disease diagnosis and identification, and cooperates with school of animal medicine of Northeast Agricultural University, School of medicine of Jiamusi University and Heilongjiang Veterinary Research Institute for product research and development and dosage form research.

本文链接: https://brand.waitui.com/03e2540d5.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

非银存款同比少减二点八四万亿元,低基数扰动+股市活跃吸引资金涌入

近日,2025年12月金融数据发布。数据显示,12月非银存款减少3300亿元,同比少减2.84万亿元。作为券商等非银行金融机构在银行处的存款,非银存款的变化常常被认为与股市涨跌互有关联,因此此次非银存款少减2.84万亿元自然也引发了市场较大关注。记者梳理的券商分析师主流观点认为,12月数据的较大变化,缘于2024年低基数的扰动。2024年12月1日开始,非银同业存款利率被纳入自律管理,导致当月非银存款大幅减少3.17万亿元,创下历史单月最大规模的收缩。兴业研究张伟康认为,非银存款12月减少3300亿元,同比少减2.84万亿元,一方面是因为季度末理财产品回表,另一方面是股市活跃吸引了资金涌入。(证券时报)

49分钟前

绩优基金2025年四季度调仓动向:聚焦景气度,优化AI持仓

随着公募基金2025年四季报的密集披露,众多绩优基金的持仓变动逐步浮出水面。总体而言,绩优基金普遍保持高仓位运作,并对持仓进行了调整。从具体调仓方向看,基金经理更加看重行业景气度,持仓逐步向AI相关产业链、创新药、机器人等板块迁移。不过,在AI相关产业中,对持仓标的进行了优化调整。(上证报)

49分钟前

三星电子将在下一代芯片中采用混合键合技术NAND

三星电子将在下一代芯片中采用混合键合技术NAND。(新浪财经)

49分钟前

热门产品掀起限购潮,基金公司差异化导购

2026开年以来,市场行情火热,多家基金公司却对旗下热门产品开启了限购模式。这一看似逆市操作的背后,既是避免基金规模快速扩张,从而摊薄现有基金持有人收益的需要,也是基金公司从规模导向向投资者回报导向转型的体现。记者梳理发现,限购的绩优基金,多聚焦在AI应用、商业航天等近期热门赛道,这些赛道交易近来较为拥挤。因此不少基金公司也在挖掘一些其他细分赛道的基金或是“固收+”、FOF等产品,为投资者均衡配置提供可选项。(中证报)

49分钟前

热门公司老股受追捧,中国S市场潜在空间扩大

人形机器人、商业航天等赛道的热门公司老股转让,带火了S交易(私募股权二级市场交易)市场。“重启未盈利企业上市,极大提振了一级股权投资人的信心,这也传导到S交易市场,含热门公司量较大的S份额被市场追捧,交易活跃度上升。”近日在沪举办的第四届私募股权基金流动性峰会上,中保投资有限责任公司副总裁陈子昊说。与会人士纷纷预计,2025年中国S交易规模有望再创新高。根据此前数据,2025年前三季度,中国私募股权二级市场交易总笔数为867笔,同比增长234%;交易总规模约923亿元,同比增长182%。(证券时报)

50分钟前

本页详细列出关于绿达生的品牌信息,含品牌所属公司介绍,绿达生所处行业的品牌地位及优势。
咨询